Table 2 lists the studies targeting mitochondria-driven cholesterol metabolites for the improvement of a NASH-related liver inflammatory condition. The liver-specific knockout of StarD1 in mice was shown to lessen steatohepatitis -riven HCC [82]. The gene discussed is STAR; the disease is metabolic dysfunction-associated steatohepatitis.